The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...